Invesaro

Stocks Comparison

3M vs Resmed: revenue, profit, margins and growth compared

3M brought in $24.9B of revenue in fiscal 2025, Resmed $5.7B in fiscal 2026. Revenue changed by +1.5% at 3M and +9.9% at Resmed on the year before, so Resmed grew faster. 3M kept 13.0% of its revenue as net profit, Resmed 26.9%. Free cash flow was $1.4B at 3M and $1.6B at Resmed.

Side by side, latest fiscal year

MMMRMD
Fiscal year endedFY2025 (December 31, 2025)FY2026 (June 30, 2026)
Revenue$24.9B$5.7B
Revenue growth+1.5%+9.9%
Net income$3.3B$1.5B
Net margin13.0%26.9%
Free cash flow$1.4B$1.6B
Free cash flow margin5.6%29.2%
Earnings per share (diluted)$6.00$10.43
Cash$5.2B$1.5B
Debt$12.6B$399.4M
Price to earnings28.221.3
Market value$87.3B$32B
Dividend yield1.72%1.08%
Rank by revenue in sector#25 of 742 · Health care#61 of 742 · Health care

Over the years

Revenue
MMM FY2018: $32.8BMMM FY2019: $32.1BMMM FY2020: $32.2BMMM FY2021: $35.4BMMM FY2022: $26.2BMMM FY2023: $24.6BMMM FY2024: $24.6BMMM FY2025: $24.9BRMD FY2019: $2.6BRMD FY2020: $3BRMD FY2021: $3.2BRMD FY2022: $3.6BRMD FY2023: $4.2BRMD FY2024: $4.7BRMD FY2025: $5.1BRMD FY2026: $5.7BFY18FY19FY20FY21FY22FY23FY24FY25FY26
MMM $24.9BRMD $5.7B
Net income
MMM FY2018: $5.3BMMM FY2019: $4.5BMMM FY2020: $5.4BMMM FY2021: $5.9BMMM FY2022: $5.8BMMM FY2023: -$7BMMM FY2024: $4.2BMMM FY2025: $3.3BRMD FY2019: $404.6MRMD FY2020: $621.7MRMD FY2021: $474.5MRMD FY2022: $779.4MRMD FY2023: $897.6MRMD FY2024: $1BRMD FY2025: $1.4BRMD FY2026: $1.5BFY18FY19FY20FY21FY22FY23FY24FY25FY26
MMM $3.3BRMD $1.5B
Net margin
MMM FY2018: 16.3%MMM FY2019: 14.1%MMM FY2020: 16.9%MMM FY2021: 16.7%MMM FY2022: 22.1%MMM FY2023: -28.4%MMM FY2024: 17.0%MMM FY2025: 13.0%RMD FY2019: 15.5%RMD FY2020: 21.0%RMD FY2021: 14.8%RMD FY2022: 21.8%RMD FY2023: 21.3%RMD FY2024: 21.8%RMD FY2025: 27.2%RMD FY2026: 26.9%FY18FY19FY20FY21FY22FY23FY24FY25FY26
MMM 13.0%RMD 26.9%
Revenue growth
MMM FY2019: -1.9%MMM FY2020: +0.1%MMM FY2021: +9.9%MMM FY2022: -26.0%MMM FY2023: -5.9%MMM FY2024: -0.1%MMM FY2025: +1.5%RMD FY2020: +13.4%RMD FY2021: +8.1%RMD FY2022: +11.9%RMD FY2023: +18.0%RMD FY2024: +10.9%RMD FY2025: +9.8%RMD FY2026: +9.9%FY19FY20FY21FY22FY23FY24FY25FY26
MMM +1.5%RMD +9.9%
Free cash flow
MMM FY2018: $4.9BMMM FY2019: $5.4BMMM FY2020: $6.6BMMM FY2021: $5.9BMMM FY2022: $3.8BMMM FY2023: $5.1BMMM FY2024: $638MMMM FY2025: $1.4BRMD FY2019: $390.3MRMD FY2020: $706.9MRMD FY2021: $634MRMD FY2022: $216.3MRMD FY2023: $573.6MRMD FY2024: $1.3BRMD FY2025: $1.7BRMD FY2026: $1.6BFY18FY19FY20FY21FY22FY23FY24FY25FY26
MMM $1.4BRMD $1.6B

Fiscal years as each company reports them; the two may end in different months.

Questions about 3M and Resmed

Which is bigger by revenue, 3M or Resmed?

3M is bigger by revenue: $24.9B in fiscal 2025, against $5.7B for Resmed in fiscal 2026.

Which keeps more of its revenue as profit, 3M or Resmed?

3M had a net margin of 13.0% in fiscal 2025; Resmed had 26.9% in fiscal 2026.

Which grew revenue faster, 3M or Resmed?

In their latest fiscal years revenue changed by +1.5% at 3M and +9.9% at Resmed.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies